Two Chronic Conditions. One Breakthrough Solution. ZyCal Bioceuticals Launches Ostinol: The First Supplement That Grows New Bone And Cartilage Tissue.

News provided by

ZyCal Bioceuticals

Jul 08, 2015, 09:00 ET


Toms River, NJ (PRWEB) July 08, 2015 -- An estimated 110 million people suffer with poor bone and joint health. Millions more are just years away. And many menopausal women face an increased risk for myocardial infarction due to calcium taken for bone health.

To help those suffering from these chronic conditions, ZyCal Bioceuticals today announced the launch of Ostinol™ Bone and Cartilage Stimulating Proteins – the first clinically proven supplement to grow both new bone and cartilage tissue, now available directly to consumers.

James Scaffidi, President and CEO, ZyCal Bioceuticals, said, “For years, people have been told to take their calcium and minerals as a preventative measure for good bone and joint health. However, for bones, the National Osteoporosis Foundation reports that it is the loss of minerals and bone tissue that leads to poor bone health. Independent studies show that calcium alone cannot regrow bone tissue.

“With 40 years of research behind it, the bio-active protein complex in Ostinol™ is the only all-natural supplement clinically proven to GROW new bone tissue, new cartilage tissue and fight inflammation. This powerful bio-active protein, used by orthopedic surgeons to help in safely grow bone tissue post-operative, is now available for consumer purchase for the first time.”

Proven Science At Work

As some people age, they lose the ability to produce enough of the vital, bio-active proteins found in Ostinol™, resulting in poor bone and joint health. These natural, key bio-active proteins are required, on a daily basis, to activate and transform key cells in our bones and joints so that new, healthy bone and cartilage tissue can be replenished. When people stop producing these critical proteins, our bodies start to break down, resulting in significant health problems:

• Loss of Bone Tissue: Once bone tissue breaks down, calcium and mineral supplements have nothing to bind to, resulting in thinning bones that are weak, fragile, and at risk of fracture.
• Thinning of cartilage lining: With thinning comes aches and pains in the joints that limit movement. Glucosamine, chondroitin and MSM can only provide building blocks for cartilage tissue and cannot activate the key cells to produce new cartilage tissue.    

That’s why Ostinol™, powered by Cyplexinol bio-active protein, was created. Cyplexinol is an all-natural, unique protein complex that naturally stimulates key stem cells to become osteoblasts (bone-building cells) and chondrocytes (cartilage building cells) for new, healthy bone and cartilage tissue. And, Ostinol provides a powerful immuno-protective effect resulting in rapid clinic benefits in as fast as seven days.*

In a published seven-year long case study, a 59-year-old female, nonsmoker was diagnosed with menopause-associated osteoporosis by a local health center. Prior to using Ostinol™, the woman’s bone density DXA (dual energy x-ray absorptiometry) score declined for five years, despite calcium, and got so low that she was osteoporotic. In just three years using Ostinol™, her DXA score increased by 52 percent from her lowest score, indicating normal bone density. **

A published, peer-reviewed clinical trial, a double-blind, placebo controlled study on the efficacy and safety of Cyplexinol in relieving pain and stiffness on 87 participants 55 years and older with moderate to severe osteoarthritis of the hip or knee, found that 90 percent reported reduction in pain and 83 percent reported reduction in stiffness.***

While calcium and other minerals are great for fortifying bone tissue for post-menopausal women, it can also be a health risk. With the lack of bone tissue, calcium can build up in coronary arteries leading to a significant increase incidence in myocardial infarction. In 2010 the British Medical Journal of Science (http://www.bmj.com/content/341/bmj.c3691 ) published these findings from a meta-analysis.

However, when adding Ostinol™, new bone tissue is stimulated to grow – providing the critical bone surface for calcium to bind. This process of producing new bone tissue, fortified by calcium, is the natural way bones grow, which properly utilizes calcium so it does not accumulate in the wrong parts of the body.

Previously available only to healthcare professionals, the bio-active proteins in Ostinol™ are backed by 40 years of scientific and medical research, been used by surgeons for 25 years and orally for eight years by health care professionals with great clinical success.

Ostinol™ is only available at http://www.ostinol.com and comes in three oral strengths from 150mg to 450mg to address a variety of the bone and joint conditions. Pricing begins at $45 for 30 tablets of Ostinol™ 150.

"The launch of Ostinol™ is an important milestone for ZyCal Bioceuticals and represents our commitment to developing new, safe and effective supplements that address unmet consumer needs," said Scaffidi. "As we age, pain can disrupt life so much and take us away from the things we love to do. With Ostinol™, consumers can now benefit from our science to take charge of their bodies and enjoy life as it was intended."

---------------------------------------------

Clinical studies are available for review at http://www.ostinol.com/clinical-studies.

About ZyCal Bioceuticals

Headquartered in Toms River, New Jersey, ZyCal Bioceuticals Healthcare Co., Inc. (http://www.zycalbio.com) is a nutritional supplement company focused on manufacturing and marketing of biologically active proteins that address bone and joint conditions for consumers, healthcare providers and their patients. Since its founding in 2006, ZyCal has developed and launched the first biologically active nutritional supplement leveraging 40 years of research and commitment to helping live better lives.

Our mission is to offer innovative, premium nutritional bone and joint supplements that enrich people’s lives. To fulfill its mission, we are committed to providing superior products and service that help change people’s lives.
http://www.zycalbio.com

Media Relations Contact
Scott Carpenter / 813-210-0383 / scott(at)nextgreatbrand(dot)com

Scott Carpenter, ZyCal Bioceuticals, http://www.ostinol.com, +1 813-210-0383, [email protected]